Related Experiment Video

Updated: Mar 20, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.2K

Vaccines against tuberculosis: A review

Salil Bhargava1, Satyadeo Choubey2, Satyendra Mishra3

  • 1Prof & Head, Dept. of Chest & TB MGM Medical College Indore, India.

The Indian Journal of Tuberculosis
|May 29, 2016
PubMed

Insights

An effective tuberculosis (TB) vaccine is needed, as the current BCG vaccine is insufficient for pulmonary TB. New vaccine candidates require extensive research for safety and efficacy before widespread use.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health burden, necessitating improved preventative strategies.
  • The Bacillus Calmette-Guérin (BCG) vaccine offers protection against severe childhood TB but lacks efficacy in pulmonary TB.
  • There is a critical unmet need for a more effective TB vaccine.

Purpose of the Study:

  • To highlight the limitations of the current BCG vaccine for tuberculosis.
  • To emphasize the ongoing need for novel and effective TB vaccine development.
  • To underscore the importance of rigorous safety and efficacy evaluations for new TB vaccine candidates.

Main Methods:

  • Literature review on TB vaccine efficacy and development.
  • Analysis of the immunological response to BCG vaccination.
  • Examination of current TB vaccine candidates in clinical trials.

Main Results:

  • BCG vaccine demonstrates limited efficacy against pulmonary tuberculosis in adults.
  • Several new TB vaccine candidates are progressing through clinical trials.
  • Data on the long-term safety and efficacy of new candidates is still pending.

Conclusions:

  • Development of a broadly protective and effective TB vaccine is a high priority.
  • New TB vaccine candidates require thorough assessment before integration into national immunization programs.
  • Continued research is essential to combat the global impact of tuberculosis.
Keywords:
BCGTuberculosisVaccine

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.8K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
746
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
623
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Vaccinations01:51

Vaccinations

Overview
53.4K